Effects of Pilocarpine Hydrochloride and Cevimeline on Submandibular/ Sublingual Salivation in Rat Xerostomia Model Produced by X-Ray Irradiation
暂无分享,去创建一个
[1] Christian C Felder,et al. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. , 2002, Molecular pharmacology.
[2] R. Eglen,et al. Therapeutic opportunities from muscarinic receptor research. , 2001, Trends in pharmacological sciences.
[3] K. Kohsaka,et al. Pharmacokinetics of SNI-2011 (1) : Absorption, Distribution, Metabolism and Excretion of 14C-SNI-2011 in Rats , 2001 .
[4] M. Sugimoto,et al. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies. , 2000, Japanese journal of pharmacology.
[5] Y. Iga,et al. (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors. , 1998, Japanese journal of pharmacology.
[6] T. Tomizuka,et al. Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs. , 1997, European journal of pharmacology.
[7] Y. Marmary,et al. Irradiation-induced damage to the salivary glands: the role of redox-active iron and copper. , 1997, Radiation research.
[8] M. Katagiri,et al. Salivary secretion and histopathological effects after single administration of the muscarinic agonist SNI-2011 in MRL/lpr mice. , 1994, Archives internationales de pharmacodynamie et de therapie.
[9] J. Johnson,et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. , 1993, The New England journal of medicine.
[10] T. Masuhara,et al. Subtypes of the muscarine receptors that are involved in pilocarpine-induced secretion of saliva from rat sublingual glands , 1992 .
[11] R. Henriksson,et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. , 1992, European journal of cancer.
[12] B. Baum,et al. Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems. , 1991, The American journal of physiology.
[13] A. Vissink,et al. Acute irradiation effects on morphology and function of rat submandibular glands. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[14] M. Terai,et al. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954. , 1990, European journal of pharmacology.
[15] T. Daniels,et al. Effectiveness of pilocarpine in postradiation xerostomia , 1987, Cancer.
[16] W. E. Wright,et al. Therapy-induced dysfunction of salivary glands: implications for oral health. , 1985, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[17] L. Tabak,et al. Role of salivary mucins in the protection of the oral cavity. , 1982, Journal of oral pathology.
[18] J. B. Drane,et al. Prevention of Xerostomia-Related Dental Caries in Irradiated Cancer Patients , 1977, Journal of dental research.
[19] C. Dawes. Rhythms in salivary flow rate and composition. , 1974, International journal of chronobiology.